Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0216402 SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC-FUSION PROTEIN
The present invention provides a method of treating cancer with a combination of IL-2 and an integrin-binding-Fc fusion protein. The methods of the invention...
2017/0216401 COMBINATION FOR USE IN A METHOD OF TREATING CANCER
The present invention refers to a combination of a TGF-beta inhibitor selected from the group consisting of an ALK-5 inhibitor, a neutralizing ...
2017/0216400 NOVEL USE OF FIBROBLAST GROWTH FACTOR 2
The present invention provides a novel use of fibroblast growth factor 2 (FGF-2), i.e., a use of FGF-2 in preparation of medicine. The uses of the medicine are...
2017/0216399 COMPOSITIONS, METHODS AND USES FOR PROTECTING WHITE BLOOD CELLS FROM SUPPRESSION OR DEATH
Provided herein are compositions, methods and uses of humanin or a humanin analog, for example, in treating a subject with humanin or a humanin analog, in...
2017/0216398 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES
The invention provides a Pseudomonas exotoxin A (PE) comprising an amino acid sequence having a substitution of one or more of amino acid residues E420, D463,...
2017/0216397 STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity,...
2017/0216396 DAPTOMYCIN FORMULATIONS AND USES THEREOF
Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can...
2017/0216395 LOW-BURST POLYMERS AND METHODS TO PRODUCE POLYMER
A PLG copolymer material, termed a PLG(p) copolymer material, adapted for use in a controlled release formulation for a bioactive material is provided, wherein...
2017/0216394 METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
The disclosure relates to methods for treating a subject suffering from a burn injury or associated complications by administering to the subject an effective...
2017/0216393 METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS
Provided are methods and compositions for maintaining the viability of photoreceptor cells and/or retinal pigment epithelial cells in a subject with an ocular...
2017/0216392 NOVEL GLP-1 RECEPTOR MODULATORS
Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic...
2017/0216391 HYDROPHILIC ANTIBODY-DRUG CONJUGATES
Hydrophilic Linkers, Drug-Linker compounds, Drug-Ligand Conjugate compounds and Ligand-Linkers and methods of making and using the same are provided.
2017/0216390 COMPOSITION COMPRISING THE EXTRACT OF HERBS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS
This invention relates to a pharmaceutical composition and a health functional food for preventing or improving neurodegenerative disorders comprising mixed...
2017/0216389 Date Pit Composition for the Treatment of Animals
A method of treating or preventing bacterial infection in an animal comprises administering an effective amount of degraded date pits. Degraded date pits can...
2017/0216388 COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH
An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and...
2017/0216387 ROASTED LAURINA COFFEE, METHOD FOR ITS PREPARATION, AND USE FOR PREVENTING METABOLIC SYNDROME
A roasted coffee of Coffea arabica var. Laurina a powder of which comprises from 5.0 to 10.0 mg per gram of powder (mg/g) trigonelline and from 3.0 to 8.0 mg/g...
2017/0216386 COMPOSITION FOR HAIR LOSS PREVENTION OR HAIR GROWTH STIMULATION COMPRISING ARTEMISIA UMBELLIFORMIS EXTRACT
Disclosed is a novel use of a composition comprising as an active ingredient an Artemisia umbelliformis extract. A composition according to the present...
2017/0216385 LONGEVITY GENE EXPRESSION ENHANCER
The present invention provides a novel sirtuin-1 activating agent, and a formulation for suppressing cell senescence caused by oxidative stress, comprising the...
2017/0216384 USE OF DEHYDROEBURICOIC ACID FROM ANTRODIA CAMPHORATA IN THE TREATMENT OR PREVENTION OF DIABETES AND HYPERLIPIDEMIA
The present invention provides a method for treating type 1 diabetes, hyperlipidemia or hepatic lipid accumulation by using dehydroeburicoic acid, as well as a...
2017/0216383 COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND REDUCE LOW DENSITY LIPOPROTEIN (LDL) PEROXIDATION IN...
In accordance with a non-limiting example, an algae based oil is used in place of a krill oil to treat low density lipoprotein (LDL) oxidation in humans by...
2017/0216382 Oncolytic Poliovirus for Human Tumors
Human clinical use of a chimeric poliovirus construct has demonstrated excellent anti-tumor effect. The mechanism of action is believed to involve both viral...
2017/0216381 Oncolytic Herpes Simplex Virus And Therapeutic Uses Thereof
The present invention relates to variants of herpes simplex virus (HSV) that selectively infect and replicate in cancer cells, including HSV strains that...
2017/0216380 BENEFICIAL EFFECTS OF BACTERIOPHAGE TREATMENTS
The invention elates to use of one or more bacteriophages in vivo in a human or animal in order to induce sensitivity to chemical antibiotics in bacterial...
2017/0216379 AGENT FOR IMPROVING OR MAINTAINING QOL
[Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality...
2017/0216378 HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and...
2017/0216377 METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available,...
2017/0216376 NOVEL STRAIN OF LACTOBACILLUS RHAMNOSUS AND ITS METABOLITES FOR USE IN INHIBITING XANTHINE OXIDASE AND TREATING...
A method for inhibiting xanthine oxidase and for reducing uric acid levels using a composition obtained by culturing Lactobacillus rhamnosus in a medium. Also...
2017/0216375 Neonatal Microbiome Supplementation
The present invention aims to prevent and/or treat health-related conditions in infants born with a non-optimal intestinal microbiome, by providing specific...
2017/0216374 MICROENCAPSULATED PROBIOTIC BACTERIA
Microencapsulated probiotic bacteria protected from degradation by acidic aqueous solutions, high bile salt concentrations, elevated temperatures, and...
2017/0216373 Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin
The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which...
2017/0216372 COMPOSITIONS AND METHODS FOR FECAL MICROBIOTA-RELATED THERAPY
The present application provides microbiota-related compositions, methods, and dosing regimens for treating various microbiota-related disorders with improved...
2017/0216371 METHODS FOR INHIBITING TUMOR GROWTH USING ANAEROBE MICROORGANISMS
Methods of inhibiting or reducing tumor metabolism and growth are disclosed. A composition containing oxygen scavenging membrane fragments and anaerobe...
2017/0216370 BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING PROPIONATE CATABOLISM
The present disclosure provides engineered bacterial cells comprising a heterologous gene encoding a propionate catabolism enzyme. In another aspect, the...
2017/0216369 WOUND HEALING COMPOSITIONS INVOLVING MEDICINAL HONEY, MINERAL IONS AND METHYLGLYOXAL, AND METHODS OF USE
The invention provides compositions based on either medicinal honey containing broad spectrum antibacterial activities of peroxide, polyphenols and...
2017/0216368 PHARMACEUTICAL COMPOSITION FOR PREVENTING, TREATING, AND CURING PSORIASIS INCLUDING SNAIL SLIME, CHAMOMILE, AND...
The invention relates to a pharmaceutical composition consisting of snail slime of Helix aspersa muller (Cryptophalus aspersus) (5% to 50%), chamomile extract...
2017/0216367 Treatment of diseases and conditions caused by increased vascular permeability
The invention is directed to methods for the treatment of diseases and conditions caused by increased vascular permeability. The invention is also directed to...
2017/0216366 CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT...
The present invention relates to a conditioned medium (CM) which is obtained by culturing, in a liquid culture medium, placental mesenchymal stem cells...
2017/0216365 MARKERS OF DEFINITIVE ENDODERM
Disclosed herein are reagent-cell complexes comprising one or more definitive endoderm cells. Also described herein are compositions for detecting definitive...
2017/0216364 APOPTOTIC BODIES
This disclosure relates to apoptotic bodies. The disclosure particularly relates to a composition comprising the apoptotic bodies. The disclosure further...
2017/0216363 NANOPARTICLE MODIFICATION OF HUMAN ADIPOSE-DERIVED MESENCHYMAL STEM CELLS FOR TREATING BRAIN CANCER AND OTHER...
The presently disclosed subject matter provides compositions, methods, and kits for transfecting adipose-derived mesenchymal stem cells (AMSCs) in freshly...
2017/0216362 CELL SHEET COMPOSITION FOR INHIBITING PROGRESSION OF RENAL DISORDER, METHOD OF PRODUCING THE SAME, AND METHOD...
The present invention provides a method of inhibiting progression of or preventing renal disorder, the method comprising applying a cell sheet composition for...
2017/0216361 METHODS OF TREATING EXERCISE-INDUCED PULMONARY HEMORRHAGE
Provided herein are methods of treating EIPH in a subject in need thereof. The methods comprise administering an effective amount of a pharmaceutical...
2017/0216360 METHODS AND COMPOSITIONS FOR IMPROVING HOMING OF CELLS INCLUDING MESENCHYMAL STEM CELLS
The disclosure relates to methods and compositions for improving homing of cells including mesenchymal stem cells (MSCs). Compositions include compounds...
2017/0216359 Patient-and Condition-Specific Platelet Transfusion Support
Determining and implementing individualized platelet support regimens (e.g., administering specified platelet numbers; and, schedules for administration or...
2017/0216358 METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA
Disclosed herein are methods and compositions for modulating the expression of a HLA locus, including cells that lack expression of one or more classic HLA...
2017/0216357 MODULATED IMMUNODOMINANCE THERAPY
The invention involves generating a T cell response to subdominant antigens and using the cells to therapeutically change the cellular homeostasis and nature...
2017/0216356 IMMUNOTHERAPY USING REDIRECTED ALLOGENEIC CELLS
A method of treating a disease, such as cancer, by administering to a subject in need of such treatment an effective amount of allogeneic T cells with a MHC...
2017/0216355 Methods and Compositions for Enhancing T Cell Function and Survival
It has been discovered that the inhibition of PI3K-.delta., but not PI3K-.alpha. or PI3K-.beta., delays the terminal differentiation of CD8 T cell and...
2017/0216354 CLINICALLY USEFUL NON-ANTIGEN PULSED DENDRITIC CELLS
Disclosed are compositions, methods of use, and pharmaceutical preparations useful for treatment of cancer. In one embodiment dendritic cells (DC) are...
2017/0216353 Inoculation by Applying Nanosecond Pulsed Electric Fields to a Biopsy and Reintroducing the Treated Biopsy to...
A subject is inoculated from a disease by exposing a biopsy of a tumor or other abnormal growth to a nanosecond pulsed electric field (nsPEF). A sufficient...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.